Report cover image

Healius Ltd (HLS) - Financial and Strategic SWOT Analysis Review

Publisher GlobalData
Published Dec 29, 2025
Length 48 Pages
SKU # GBDT20700034

Description

Healius Ltd (HLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Healius Ltd (Healius), formerly Primary Health Care Ltd, is a healthcare company that offers a range of medical and health-related services and healthcare technology solutions to medical and allied health professionals. Its major services include anatomical pathology, clinical pathology, IVF centers, genomic diagnostics, day hospitals and veterinary pathology. The company also offers para-medical, medical and related services, and functions as a daycare surgery operator. It offers healthcare technology solutions to medical practitioners, medical practices and hospitals. The company markets its products under the brand names abbott, agilex biolabs, dorevitch, gatrolab, genomic diagnostics, iq pathology, kossard, laverty, qml, tml, vetnostics, western diagnostic pathology. The company operates medical and pathology centers in Australia and Montserrat with operations in all states and territories. Healius is headquartered in Sydney, New South Wales, Australia.

Healius Ltd Key Recent Developments

Dec 08,2025: Healius : Board Changes
Dec 01,2025: Healius wins contract for supply of services to Australian Defence Force
Sep 30,2025: Healius Limited Strengthens Leadership with New Director Appointment
Apr 28,2025: Healius : Changes to CEO Terms of Employment

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company

Table of Contents

48 Pages
Section 1 - About the Company
Healius Ltd - Key Facts
Healius Ltd - Key Employees
Healius Ltd - Key Employee Biographies
Healius Ltd - Major Products and Services
Healius Ltd - History
Healius Ltd - Company Statement
Healius Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Healius Ltd - Business Description
Healius Ltd - Corporate Strategy
Healius Ltd - SWOT Analysis
SWOT Analysis - Overview
Healius Ltd - Strengths
Healius Ltd - Weaknesses
Healius Ltd - Opportunities
Healius Ltd - Threats
Healius Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Healius Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Healius Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Healius Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 08, 2025: Healius : Board Changes
Dec 01, 2025: Healius wins contract for supply of services to Australian Defence Force
Sep 30, 2025: Healius Limited Strengthens Leadership with New Director Appointment
Apr 28, 2025: Healius : Changes to CEO Terms of Employment
Feb 20, 2025: Healius Appoints Neil Vinson asNon-Executive Director
Jan 01, 2025: Board membersMeet the leaders guiding our vision.
Nov 29, 2024: Healius Announces Board Changes
Jun 14, 2024: Healius Announces Group Executive of Pathology departure
Jun 12, 2024: Australian Infrastructure Signs on to $700 Million Renewable Energy Program to Reduce Emissions & Costs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Healius Ltd, Key Facts
Healius Ltd, Key Employees
Healius Ltd, Key Employee Biographies
Healius Ltd, Major Products and Services
Healius Ltd, History
Healius Ltd, Subsidiaries
Healius Ltd, Key Competitors
Healius Ltd, Ratios based on current share price
Healius Ltd, Annual Ratios
Healius Ltd, Annual Ratios (Cont...1)
Healius Ltd, Annual Ratios (Cont...2)
Healius Ltd, Interim Ratios
Healius Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Healius Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Healius Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Healius Ltd, Performance Chart (2021 - 2025)
Healius Ltd, Ratio Charts
Healius Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Healius Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.